Identification of PLK1 as a New Therapeutic Target in Mucinous Ovarian Carcinoma

Affatato, R; Carrassa, L; Chila, R; Lupi, M; Restelli, V; Damia, G

Damia, G (corresponding author), Ist Ric Farmacol Mario Negri IRCCS, Lab Mol Pharmacol, Via Mario Negri 2, I-20156 Milan, Italy.

CANCERS, 2020; 12 (3):

Abstract

Mucinous epithelial ovarian cancer (mEOC) is a rare subset of epithelial ovarian cancer. When diagnosed at a late stage, its prognosis is very poor, a......

Full Text Link